Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats.

Journal Article (Journal Article)

Although the mutant dwarf rat has been proposed as a model of growth hormone (GH) deficiency, few studies have addressed its cardiovascular abnormalities. Therefore, the aim of the present study was to investigate cardiac structure and function in mutant dwarf rats in vivo before and after chronic GH administration, by means of transthoracic Doppler echocardiography. To this purpose, forty 90-day-old female dwarf rats were randomized to receive either GH treatment or placebo. Twenty age-and sex-matched Lewis rats (200-250 g) served as the control group. All rats underwent echocardiograms before receiving any drug and after 3 weeks of therapy. Echocardiographically detected left ventricular mass indexed to tibial length was reduced by 41% in dwarf rats compared to the control group. Such relative cardiac atrophy was also evident at the myocyte level, and was fully reversible after GH therapy. In contrast to the control group, dwarf rats also showed a reduction of left ventricular diastolic volumes normalized to tibial length and impaired cardiac performance as suggested by the reduction of cardiac index, abnormal stress-shortening relations, and a significant elevation of total peripheral vascular resistance. All these abnormalities were reversible upon GH therapy for 3 weeks. In conclusion, GH plays an important role in maintaining a normal cardiac structure and function. Since the observed changes are similar to those seen in GH-deficient men, the mutant dwarf rat represents a faithful animal model of GH deficiency.

Full Text

Duke Authors

Cited Authors

  • Longobardi, S; Cittadini, A; Strömer, H; Katz, SE; Grossman, JD; Clark, RG; Morgan, JP; Douglas, PS

Published Date

  • October 2000

Published In

Volume / Issue

  • 10 / 5

Start / End Page

  • 242 - 247

PubMed ID

  • 11042020

International Standard Serial Number (ISSN)

  • 1096-6374

Digital Object Identifier (DOI)

  • 10.1054/ghir.2000.0160


  • eng

Conference Location

  • Scotland